Intellectual Property India Publishes Patent Application for 'Compositions Useful For Modulating Splicing' Filed by Skyhawk Therapeutics, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517074936 A) filed by Skyhawk Therapeutics, Inc., Waltham, U.S.A., on Aug. 6, for 'compositions useful for modulating splicing.'

Inventor(s) include Ratni, Hasane; Konetzki, Ingo; Lucas, Brian; and Luzzio, Michael.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present application discloses compounds of Formula (I) that modulate splicing of a pre-mRNA, encoded by genes, and methods of treating diseases and conditions associated with gene expression or activity of proteins encoded by genes, such as Spinocerebellar Ataxia 3 (SCA3 or Machado-Joseph Disease)."

The patent application was internationally filed on Jan. 18, 2024, under International application No.PCT/US2024/012052.

Disclaimer: Curated by HT Syndication.